15% OFF Cerebrolysin – 60mg/vial (Research Use Only)
Availability: In stock
3–4 vials — 5% off · 5–9 vials — 10% off · 10+ vials — 15% off
Applied automatically in the cart. Combines with a discount code up to 20% off in total, and stacks on top of the subscription discount.
Research Disclaimer: All products currently listed on this site are for research purposes only.
Overview
Cerebrolysin is a standardized low-molecular-weight peptide fraction derived from purified porcine brain proteins, developed in Austria and used clinically in numerous countries for neurodegenerative and cerebrovascular conditions. Its composition includes a mixture of neuropeptides, neurotrophic factor fragments, and amino acids in the <10 kDa range, with documented neurotrophic, neuroprotective, and neuroplasticity-enhancing activity profiles in published preclinical research. The compound’s clinical regulatory history and extensive published mechanistic literature — spanning BDNF, NGF, and GDNF pathway interactions, synaptogenesis markers, and neuroprotection in ischemia models — make it a frequently referenced compound in CNS research.
What It Is
Cerebrolysin is an aqueous solution of low-molecular-weight peptides and free amino acids derived from standardized enzymatic hydrolysis of purified porcine brain proteins, standardized to contain approximately 25% active peptide fragments (<10 kDa). The preparation includes fragments with BDNF-like, NGF-like, and GDNF-like neurotrophic activity as characterized in published binding and cell biology research. The solution also contains free amino acids including glutamate, aspartate, GABA, and others naturally present in brain tissue.
Key Research Applications
- Neurotrophic factor mimetic activity (BDNF, NGF, GDNF-like) and TrkB/TrkA receptor research
- Synaptogenesis, dendritic spine density, and synaptic plasticity biomarker studies
- Neuroprotection in ischemia-reperfusion and hypoxia preclinical models
- Alzheimer’s disease preclinical modeling — amyloid, tau, and neuroinflammation studies
- Neuroplasticity, memory consolidation, and cognitive function marker research
- Stroke recovery modeling and neurological rehabilitation biomarker studies
- Neurotrophic factor receptor (TrkB, p75NTR, GFRα) interaction research
- Comparative neuropeptide mixture vs. recombinant neurotrophic factor studies
Technical Specifications
| Type | Porcine brain-derived neuropeptide fraction |
| Active Peptide Content | ~25% of total preparation |
| Molecular Weight Range | <10 kDa (peptide components) |
| Form | Lyophilized powder (from sterile solution) |
| Vial Size | 60mg (lyophilized equivalent) |
| Storage | −4 °F long-term; protect from light |
FOR RESEARCH USE ONLY. Not intended for human or veterinary consumption, medical diagnosis, treatment, or prevention of any disease or condition. This product has not been evaluated by the FDA or any regulatory agency. Must be handled by qualified research personnel in a compliant laboratory setting. These statements have not been evaluated by the Food and Drug Administration.
Not sure which compounds fit your research? Browse the Research Hub →
- Processing: Orders ship within 1–2 business days
- Domestic delivery: 3–5 business days via USPS Priority / UPS Ground
- Free shipping on orders over $100
- Temperature handling: Cold-chain packaging available on request for lyophilized peptides
- Tracking: Emailed automatically at time of dispatch
- Store lyophilized (dry) peptides at −4 °F for long-term stability
- Protect from light and moisture at all times
- Do not freeze
- Where the Storage row in the product specification above differs, follow the specification
Pairs Well With
Related research products
Reviews
There are no reviews yet.